Search

Your search keyword '"de Leval, Laurence"' showing total 82 results

Search Constraints

Start Over You searched for: Author "de Leval, Laurence" Remove constraint Author: "de Leval, Laurence" Database ScienceDirect Remove constraint Database: ScienceDirect
82 results on '"de Leval, Laurence"'

Search Results

4. Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study

9. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

10. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

11. Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1

12. Genetic and phenotypic attributes of splenic marginal zone lymphoma

13. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma

16. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

17. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma

20. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas

21. P-182 - KIR3DL2 also represents a novel therapeutic target in non-cutaneous aggressive systemic peripheral T-cell lymphomas

25. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

26. ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting

27. Genomic profiling for clinical decision making in lymphoid neoplasms

28. Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study

29. Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

30. Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma

37. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

40. Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma

Catalog

Books, media, physical & digital resources